Branded

Press enter to search
Close search
Open Menu

Branded

News and information on branded drugs sold in retail pharmacies, as well as their suppliers.

The words approved in caps and red letters.

GSK obtains FDA blessing for new indication for Benlysta

GSK's Benlysta is now approved for patients with active lupus nephritis.

Agile Therapeutics launches Twirla contraceptive patch

Agile Therapeutics’ once-weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol.

An envelope with paper in it with a check mark.

Genentech’s Xofluza now is indicated to include post-exposure prevention of influenza for patients 12 years old and older after contact with a person with the flu.

Two modern office buildings.

Merck will acquire Oncolmmune, which recently announced positive findings from a Phase 3 study of its candidate for the treatment of patients with severe and critical COVID-19.

FDA headquarters.

Eli Lilly and Incyte have received emergency use authorization from the Food and Drug Administration for baricitinib in combination with remdesivir in hospitalized adult and pediatric patients age 2 years old or older with COVID-19.

The words approved in caps and red letters.

UCB’s Vimpat has received the Food and Drug Administration’s nod for primary generalized tonic-clonic seizures, as well as expanded pediatric use for people with epilepsy.

A man holding an FDA approved sign.

Eli Lilly's bamlanivimab has received the Food and Drug Administration’s nod for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.

The words approved in caps and red letters.

AstraZeneca’s Brilinta (ticagrelor) is now approved to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischemic attack.

A man holding an FDA approved sign.

Kala Pharmaceuticals' Eysuvis provides a short-term treatment of the signs and symptoms for dry eye disease.

Two modern office buildings.

Sanofi has agreed to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products.

A puzzle piece with a stick figure.

Yew Looi Liew succeeds Jean-Michel Boers as president of Boehringer Ingelheim's U.S. human pharma.

The words approved in caps and red letters.

Gilead Sciences' Veklury has been approved to treat hospitalized patients with COVID-19 who are 12 years old and older.

Pills spilling out of a vial.

The DOJ's settlement agreement will pave the way for Purdue to submit a plan of reorganization to the bankruptcy court that will transfer all of Purdue’s assets to a public benefit company.

A man holding an FDA approved sign.

Regeneron’s Inmazeb is the first FDA-approved treatment for Ebola virus infection in adult and pediatric patients.

Show More